Unique ID issued by UMIN | UMIN000020152 |
---|---|
Receipt number | R000023278 |
Scientific Title | The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients. |
Date of disclosure of the study information | 2015/12/15 |
Last modified on | 2018/11/07 22:41:22 |
The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients.
The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients.
The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients.
The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients.
Japan |
Renal cell carcinoma
Urology |
Malignancy
NO
Some molecular target therapies are effctive for the renal cell carcinoma. However, some patients are suffering from adverse events,stomatitis, hypertension, and hand-foot syndrome. The mainly aim for this study is to examine the preventive effects of royal jelly for the adverse events of the molecular target therapies.
Safety,Efficacy
The efficacy of royal jelly for the skin problem of the molecular target therapy.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
We examine this research using double-blind method. We divide the patients into two groups, royal jelly group and placebo-control group.The group of royal jelly patients take 2400mg /day royal jelly for 90 days.
The patients of placebo group take encapsulated drugs 3 times a day for 90 days
20 | years-old | <= |
Not applicable |
Male and Female
1. renal cell carcinoma patient
2. performance status 0-1
3. WBC 3000/mm3 <=
Neutro:1500/mm3 <=
PLT:100,000/mm3 <=
Hb:8g/dl <=
AST and ALT:Upper limit 3 times or less
T.Bil:1.5mg/dl =>
Crea:2.0mg/dl =>
FB:125mg/dl =>
4. Those who can start this research within two weeks after resistration.
5. those who are 20 years and older
6. those who allow the participation for this study
1. those who have possibility of the cancer death within six months
2.those who have allergy for honey
3. those who have some allergy for foods and drugs
4. those who have another cancer
60
1st name | |
Middle name | |
Last name | Yasuyoshi Miyata |
Nagasaki University Hospital
Urology and Renal transplantation
1-7-1,Samkamoto, Nagasaki, Japan
095-819-7340
int.doc.miya@m3.dion.ne.jp
1st name | |
Middle name | |
Last name | Tomohiro Matsuo |
Nagasaki University Hospital
Urology and Renal transplantation
1-7-1,Samkamoto, Nagasaki, Japan
095-819-7340
tomo1228@nagasaki-u.ac.jp
Department of Urology and Renal transplantation, Nagasaki University Hospital
Yamada Research Grant
Non profit foundation
Japan
NO
2015 | Year | 12 | Month | 15 | Day |
Unpublished
Completed
2015 | Year | 11 | Month | 01 | Day |
2015 | Year | 12 | Month | 15 | Day |
2017 | Year | 07 | Month | 31 | Day |
2017 | Year | 07 | Month | 31 | Day |
2015 | Year | 12 | Month | 10 | Day |
2018 | Year | 11 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023278
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |